NESF NextEnergy Solar Ord
NextEnergy Solar Fund Limited specializes in investments in operational solar photovoltaic (PV) assets. The fund intends primarily to acquire operating assets, but may invest in assets that are under development, that is, at the stage of origination, project planning or construction. Within this sector it intends to acquire assets that are primarily ground-based and utility-scale and which are on sites that may be agricultural, industrial, and/or commercial. It invests in solar power plants. The fund may also acquire selected building-integrated installations. It invests in electric power by solar energy and independent power producers and energy traders. It seeks to invest in the United Kingdom. It will typically seek to acquire sole ownership, but may enter into joint ventures or acquire majority interests. Where an interest of less than 100 percent in a particular asset is acquired, the fund intends to secure controlling shareholder rights through shareholders' agreements or other legal arrangements. The fund will not invest more than 30 percent of the gross asset value in any one project. In case of under developed assets it will not invest more than 10 per cent of the gross asset value. It may invest by way of equity or a mix of equity and shareholder loans.…
Industry Peers
Oil, Gas & FuelsKey Statistics
About NextEnergy Solar Ord (LON: NESF)
›
NextEnergy Solar Ord (LON: NESF) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Oil, Gas & Fuels industry, part of the Energy sector.
The shares were at 50.30 GBp on 19 November 2026, down 7.8% over 52 weeks. Its 52-week range is 43.00 GBp to 56.00 GBp: the price is 10.2% below the high and 17.0% above the low.
Its market capitalisation is 289.33M GBP.
NextEnergy Solar Ord reports return on equity of -14.0%, an operating margin of 81.1% and revenue down 42.9% year over year.
Its debt exceeds its cash by 173.51M GBP. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 50.00 GBp is 0.6% below the current price.